About this trial
The objective of this study is to investigate the efficacy of NMN supplementation in enhancing embryo developmental capacity and improving IVF success rates in patients experiencing IVF failures.
Eligibility criteria
Qualifiers
Agree to participate in the study
32-42 years old
Having at least one previous embryo implantation failure
History of low Embryo quality at day3 or day5 (according to Veeck's and Gardner's Criteria)
Disqualifiers
Ovarian endometriosis with Chocolate cysts (AFS type 3 and 4)
Patients who have taken different supplements such as coenzyme Q10, vitamin E, carnitine,niacin, nicotinamide, or other vitamin B3-related etc. within the previous month
Any medical contraindication of oocyte retrieval or subsequent procedures
Couples where the husband presents with severe sperm abnormalities
Trial design
Treatments tested in this trial
- NMN capsule
- Placebo